Cancer surveillance in patients receiving long-term hemodialysis

Anticancer Research

Volumn 22, Issue 2 B, 2002, Pages 1305-1310

  Palestini, Massimo ^a   Lucandri, Giorgio ^a   Sterpetti, Antonio ^a   Izzo, Luciano ^a   Orefici, Filina ^a   Cavallaro, Antonino ^a  

^a NONE   (Italy)

Author keywords

Cancer incidence; Epidemiology; Hemodialysis

Indexed keywords

ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RISK; CLINICAL PROTOCOL; COLON CANCER; FOLLOW UP; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; KIDNEY CANCER; LONG TERM CARE; PATIENT SELECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; RISK FACTOR; UTERUS CARCINOMA;

ADOLESCENT; ADULT; AGED; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; KIDNEY FAILURE; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; RENAL DIALYSIS;

EID: 0036327316     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Caratteristiche cliniche ed epidemiologiche di pazienti selezionati da una lunga sopravvivenza in dialisi
2. Improved survival in renal replacement therapy in Europe between 1975 and 1992. An ERA-EDTA Registry study
3. Cancer incidence in 854 kidney transplant recipients from a single institution: Comparison with normal population and with patients under dialytic treatment
4. Malignancy after renal tranplantation: Analysis of incidence and risk factors in 1700 patients followed during a 25-year period
5. The risk of ano-genital malignancies in dialysis and transplant patients
6. Malignant diseases in patients treated by dialysis and transplantation in Europe
7. Increased incidence of malignancy during chronic renal failure
8. Neoplasia in patients with chronic renal failure on long-term dialysis
9. Increased incidence of malignancy in chronic renal failure
10. Malignancies in end stage renal disease
11. Malignancy in uremia: Dialysis versus transplantation
12. High incidence of neoplasia in uremia patients receiving long-term dialysis
13. Malignant disorders and long-term survival in hemodialysis patients
14. Hemodialysis and cancer
15. Cancer in patients receiving dialysis
16. Malignant tumours in dialysis patients: A nationwide survey
17. Combined report on regular dialysis and transplantation in Europe
18. Cancer in uremic patients
19. Cancer in patients receiving long-term dialysis treatment
20. Neoplasms in dialysis patients: A population-based study
21. Incidence and mortality patterns of malignancy and factors affecting the risk of malignancy in dialysis patients
22. Cancer among patients on renal replacement therapy: A population-based survey in Lombardia, Italy
23. Malignant tumors in hemodialysis patients
24. End stage renal disease and malignancy
25. Renal adenocarcinoma and end stage kidney disease
26. Urologic cancers in uremic patients
27. Acquired cystic disease of the kidney and renal cell carcinoma in chronic renal insufficiency without dialysis treatment
28. Acquired renal cystic disease and renal adenocarcinoma in patients on long-term hemodialysis
29. Evidence for association between renal cell carcinomas and renal cystic diseases: Nationwide survey in Japan
30. Renal cell carcinoma and acquired cystic disease of the kidney in patients on long-term hemodialysis
31. Renal-cell carcinoma in uremic acquired renal cystic disease: Incidence, detection and management
32. Acquired cystic kidney disease in patients on long-term dialysis: A retrospective study on 125 autopsies. Part 1: Cysts
33. Acquired cystic kidney disease in patients on long-term dialysis: A retrospective study of 125 autopsies. Part 2: Tumors
34. Balkan endemic nephropathy and papillary cell tumors of the renal pelvis and ureters
35. Cancer in patients on dialysis for end-stage renal disease: An international collaborative study
36. Malignancy in chronic dialysis patients
37. Animal model of hemodialysis induced polycystic kidney disease
38. Amine metabolism and the small bowel in uremia
39. Significant increase of IQ-type heterocyclic amines, dietary carcinogens in the plasma of patients with uremia just before induction of hemodialysis treatment
40. Megalocytosis and chromosome aberration in patients on regular hemodialysis
41. Influence of dialysis on plasma lipid peroxidation products and antioxidant levels
42. Cancer in end-stage renal disease: Potential factors involved
43. Renal cell carcinoma in chronic hemodialysis patients. A 1990 questionnaire in Japan
44. Acquired cystic kidney disease: Occurrence, prevalence and renal cancer
45. Acquired renal cystic disease and tumor markers in chronic hemodialysis patients
46. The pathogenesis of drug-induced renal cystic disease
47. Acquired cystic disease. Replace one kidney disease with another
48. Prostatic cancer in a patient on long-term hemodialysis
49. Colon-cancer screening in dialysis patients
50. Screening for gastroenterological malignancies in new and maintenance dialysis patients
51. Elevated tumor markers in hemodialysis patients
52. CYFRA 21-1 and ProGRP, tumor markers of lung cancer, are elevated in chronic renal failure patients
53. Effect of hemodialysis on the concentration of seven tumor markers